{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
HCA Healthcare, Inc.
HCA Healthcare Stock Hits Day High with Strong Intraday Performance
HCA Healthcare, Inc. has seen a significant rise today, contrasting with the S&P 500's modest gain. Despite recent declines over the past week and month, the company has outperformed the S&P 500 on a yearly basis. It operates in the hospital industry with a market cap of USD 117,444 million.
HCA Healthcare Stock Hits Day Low of $422.19 Amid Price Pressure
HCA Healthcare, Inc. faced a notable decline in stock value, dropping significantly on April 24, 2026. The company's recent performance metrics reveal a stark contrast with the S&P 500, highlighting challenges in the hospital industry and a complex financial landscape marked by high debt levels.
HCA Healthcare Stock Hits Day High with Strong 3.17% Intraday Surge
HCA Healthcare, Inc. has demonstrated strong stock performance, significantly outperforming the S&P 500 over various time frames. The company has achieved notable growth in market capitalization and dividend yield, although it faces challenges such as a negative book value and a high PEG ratio.
HCA Healthcare Stock Hits Day Low Amid Price Pressure, Closes Down 3.14%
HCA Healthcare, Inc. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent downturns, the company has shown strong annual returns and a solid year-to-date increase. However, challenges such as a negative book value and high debt-to-equity ratio may impact its stability.
HCA Healthcare Hits New 52-Week High of $443.28, Showcasing Strong Performance
HCA Healthcare, Inc. achieved a new 52-week high of USD 443.28 on October 22, 2025, reflecting strong performance in the hospital sector with a 29.28% increase over the past year. The company has a market capitalization of USD 97,833 million and notable financial metrics, including a P/E ratio of 14.00.
HCA Healthcare Hits New 52-Week High of $439.01, Surges 28.22%
HCA Healthcare, Inc. achieved a new 52-week high of USD 439.01 on October 7, 2025, reflecting strong performance in the hospital industry. The company has seen a 28.22% growth over the past year, significantly outperforming the S&P 500, and offers a notable dividend yield.
HCA Healthcare, Inc. Hits New 52-Week High of $435.03
HCA Healthcare, Inc. reached a new 52-week high of USD 435.03 on October 6, 2025, reflecting its strong performance in the hospital sector. The company has seen a notable increase over the past year and offers a substantial dividend yield, indicating its commitment to shareholder value.
HCA Healthcare Hits New 52-Week High of $432.36
HCA Healthcare, Inc. achieved a new 52-week high of USD 432.36 on October 3, 2025, reflecting its strong performance in the hospital sector. The company has seen a 25.87% increase over the past year, with a competitive P/E ratio and a notable dividend yield, despite some challenges in financial metrics.
HCA Healthcare Hits New 52-Week High, Stock Surges 24.89%
HCA Healthcare, Inc. achieved a 52-week high of $362.00, marking a significant milestone in its strong performance within the hospital industry. The company has seen a notable increase over the past year, outpacing broader market growth, while maintaining a favorable valuation and impressive dividend yield despite challenges in return on equity and debt levels.
HCA Healthcare Hits New 52-Week High of $422.46, Surges 22.8%
HCA Healthcare, Inc. achieved a new 52-week high of USD 422.46 on September 26, 2025, reflecting strong performance in the hospital industry. The company has seen a 22.8% increase over the past year, outpacing the S&P 500, and offers a notable dividend yield while facing challenges in return on equity and debt levels.
Is HCA Healthcare, Inc. technically bullish or bearish?
As of September 4, 2025, HCA Healthcare, Inc. shows a bullish technical trend with strong MACD and moving averages, having outperformed the S&P 500 year-to-date but underperformed over the past year.
Is HCA Healthcare, Inc. overvalued or undervalued?
As of July 20, 2021, HCA Healthcare, Inc. is considered a risky investment due to its overvaluation indicated by a P/E ratio of 14, a negative Price to Book Value of -26.28, and an EV to EBITDA ratio of 9.56, despite a lower PEG ratio of 1.15 compared to peers and a strong year-to-date stock return of 33.62%.
Is HCA Healthcare, Inc. overvalued or undervalued?
As of July 20, 2021, HCA Healthcare, Inc. is considered undervalued with a P/E ratio of 14 and strong performance indicators, including a high ROCE of 27.18% and a year-to-date return of 26.18%, outperforming the S&P 500.
Is HCA Healthcare, Inc. technically bullish or bearish?
As of June 2, 2025, HCA Healthcare, Inc. shows a mildly bullish technical trend, supported by strong daily moving averages and positive weekly indicators, despite mixed signals from the monthly MACD and a mildly bearish outlook from the weekly Dow Theory.
Who are in the management team of HCA Healthcare, Inc.?
As of March 2022, the management team of HCA Healthcare, Inc. includes Chairman Thomas Frist, CEO Samuel Hazen, and several independent directors: Meg Crofton, Robert Dennis, Nancy-Ann DeParle, and Charles Holliday. They are responsible for guiding the company's strategic direction and operations.
What does HCA Healthcare, Inc. do?
HCA Healthcare, Inc. is a large-cap holding company that operates hospitals and related healthcare entities, with recent net sales of $18.32 billion and a net profit of $1.83 billion. Key metrics include a P/E ratio of 14.00 and a market cap of approximately $89.6 billion.
How big is HCA Healthcare, Inc.?
As of Jun 18, HCA Healthcare, Inc. has a market capitalization of $89.6 billion, with recent net sales of $71.6 billion and a net profit of $6.7 billion over the last four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
